EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Increased risk of reoperation and failure to attain clinically relevant improvement following autologous chondrocyte implantation of the knee in female patients and individuals with previous surgeries: a time‐to‐event analysis based on the German cartilage registry (KnorpelRegister DGOU)

Alexander Bumberger, Marco Christopher Rupp, Christian Lattermann, Anne Kleiner, Philipp Niemeyer

Knee Surgery, Sports Traumatology, Arthroscopy · 2023

DOI: 10.1007/s00167-023-07615-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Knee Surgery, Sports Traumatology, Arthroscopy, 2023. Verfasst von Alexander Bumberger und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics and Trauma Surgery, Medical University of Vienna, AKH Wien, Waehringer Guertel 18-20, 1090, Vienna, Austria. alexander.bumb…. Hauptthemen laut MEDLINE: Chondrocytes, Cartilage, Articular. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Vienna, Medizinische Universität Wien.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to analyze the risk of reoperation following autologous chondrocyte implantation (ACI) of the knee utilizing third‐generation ACI products in a time‐to‐event analysis and report on the associated patient‐reported outcome measures (PROM) in case of reoperation.

Methods

Patients undergoing ACI were included from a longitudinal database. Patient age, sex, body mass index (BMI), number of previous surgeries, lesion localization, lesion size, symptom duration, as well as time and type of reoperation was extracted. A cox proportional‐hazards model was applied to investigate the influence of baseline variables on risk of reoperation. Reoperation was defined as any type of subsequent ipsilateral knee surgery, excluding hardware removal. The Knee Injury and Osteoarthritis Outcome Score (KOOS) was utilized to compare PROM between patients with and without reoperation.

Results

A total of 2039 patients were included with 1359 (66.7%) having a minimum follow‐up of 24 months. There were overall 243 reoperations (prevalence 17.9%). Minor arthroscopic procedures ( n = 96, 39.5%) and revision cartilage repair procedures ( n = 78, 32.1%) were the most common reoperations. Nineteen patients (0.9%) reported conversion arthroplasty at 17.7 (10.4) months after ACI. Female sex (HR 1.5, 95% CI [1.2, 2.0], p = 0.002) and the presence of 1–2 previous surgeries (HR 1.5, 95% CI [1.1, 2.0], p = 0.010), or more than 2 previous surgeries (HR 1.9, 95% CI [1.2, 2.9], p = 0.004) were significantly associated with increased risk of reoperation following ACI. Significantly less patients surpassed the minimal clinically important difference (MCID) in the reoperation group at 24 months regarding the KOOS subscores pain (OR 1.6, 95% CI [1.1, 2.2]), quality of life (OR 2.2, 95% CI [1.6, 3.2]), symptoms (OR 2.0 [1.4, 2.9]), and sports (OR 2.0 [1.4, 2.8]).

Conclusion

Female patients and individuals with a history of previous surgeries face an elevated risk of requiring reoperation after undergoing ACI, which is associated with failure to attain clinically relevant improvements. A thorough evaluation of the indications for ACI is paramount, particularly when patients have a history of previous surgeries. Level of evidence Level III.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChondrocytesCartilage, ArticularHumansFemaleReoperationQuality of LifeTransplantation, AutologousKnee JointRegistries

Stichwörter der Autor:innen

ACIAnalysisArticularAutologous chondrocyte implantationAutologous chondrocyte transplantationCartilageComplicationFailureJointKneeRegenerationRegistryRestorationRevisionSurvival

Autor:innen und Institutionen

  • Department of Orthopedics and Trauma Surgery, Medical University of Vienna, AKH Wien, Waehringer Guertel 18-20, 1090, Vienna, Austria. alexander.bumberger@meduniwien.ac.at.
  • OCM, Munich, Germany. alexander.bumberger@meduniwien.ac.at.
  • The Steadman Philippon Research Institute, 181 West Meadows Drive, Suite 400, Vail, CO, USA.
  • Department of Orthopaedic Sports Medicine, Hospital Rechts Der Isar, Technical University of Munich, Munich, Germany.
  • Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Department of Orthopedics and Trauma Surgery, Medical University of Vienna, AKH Wien, Waehringer Guertel 18-20, 1090, Vienna, Austria.

Förderung

  • Medical University of Vienna
  • Medizinische Universität Wien

Zitieren

APA

Bumberger, A., Rupp, M. C., Lattermann, C., Kleiner, A., & Niemeyer, P. (2023). Increased risk of reoperation and failure to attain clinically relevant improvement following autologous chondrocyte implantation of the knee in female patients and individuals with previous surgeries: a time‐to‐event analysis based on the German cartilage registry (KnorpelRegister DGOU). Knee Surgery, Sports Traumatology, Arthroscopy. https://doi.org/10.1007/s00167-023-07615-5

Vancouver

Bumberger A, Rupp MC, Lattermann C, Kleiner A, Niemeyer P. Increased risk of reoperation and failure to attain clinically relevant improvement following autologous chondrocyte implantation of the knee in female patients and individuals with previous surgeries: a time‐to‐event analysis based on the German cartilage registry (KnorpelRegister DGOU). Knee Surgery, Sports Traumatology, Arthroscopy. 2023. doi:10.1007/s00167-023-07615-5

BibTeX
@article{Bumberger2023,
  author = {Bumberger, Alexander and Rupp, Marco Christopher and Lattermann, Christian and Kleiner, Anne and Niemeyer, Philipp},
  title = {Increased risk of reoperation and failure to attain clinically relevant improvement following autologous chondrocyte implantation of the knee in female patients and individuals with previous surgeries: a time‐to‐event analysis based on the German cartilage registry (KnorpelRegister DGOU)},
  journal = {Knee Surgery, Sports Traumatology, Arthroscopy},
  year = {2023},
  doi = {10.1007/s00167-023-07615-5}
}
Kostenlos starten →